Ultragenyx Pharmaceutical logo
Ultragenyx Pharmaceutical
RARE | NASDAQ
Chart Builder DCF Calculator
$15.90
-$0.18 (-1.12%)
At close: Nov 16, 2026, 4:00 PM ET
$15.85
-$0.05 (-0.31%)
After-hours: Nov 16, 2026, 7:30 PM ET

Ultragenyx Pharmaceutical Statistics

Key statistics explained

Market Data

$1.62B
$2.54B
0.32
3.79M
102.1M
2.33%
N/A
NASDAQ
US90400D1081

Price Performance

9.3%
-39.1%
-34.3%
-30.9%
-51.1%
-60.2%
-79.5%
9.4%
-51.9%
-27.3%
-15.1%

Valuation

-3.06
86.63
-0.25
0.04
2.22
1.70
-4.31
-3.67
-2.81
-3.71
3.48
-5.63
-6.09
-5.75
-32.6%
-27.3%
-35.6%

Financial Health

$920M
$1.19B
$266M
$1.19B
1.40
1.25
-3.15
-2.84
-2.68
-0.37
-5.71
-5.66
3

Margins & Profitability

82.9%
-64.1%
-57.1%
-71.8%
-60.5%
-79.0%
18.5%
-30.6%

Returns

-44.1%
213.2%
-52.7%
-58.6%
-53.9%

Historical Growth (CAGR)

21.2%
15.2%
137.5%
10.9%
16.7%
-1.1%
-0.3%
3.8%
-7.2%

Analyst Forecasts

Buy
17
41.4%
18.4%
Feb 11, 2027
$2.39
-285.3%
$226.63M
9.5%

Fair Value Estimates

N/A
N/A
N/A
N/A
$23.00
44.7%

Cash Flow

$-436.83M
$-441.77M
$-577.06M
-$4.33
-$4.28
-59.8%

Income Statement

$730M
$605M
$-468M
$-417.22M
$-524M
-$5.19
$532.46K
$-382.2K
1,371

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.